Vaccination Phase 3 | Key decisions taken to boost the COVID vaccination supply in India

The third phase of COVID vaccination is currently underway amidst rising COVID cases, many states have not been able to begin the COVID vaccination drive for the people in the age group of 14-44. As a result, some big decisions were taken by the government. A number of changes have now been introduced. Bharat Biotech which is producing Covaxin has agreed to share the formulation of Covaxin with other manufacturers as well. Which will further help India in increasing the production of Covaxin. There are two vaccines at the moment in India, Covishield and Covaxin. It is also reported that more foreign COVID vaccines may be approved. Watch the video to know more!

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting